Stock Earnings

Question 1

What are Mesoblast Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Mesoblast Ltd has a total asset of $784, Net loss of $-102

Question 2

What are the key financial ratios for MEOBF?

Accepted Answer

Mesoblast Ltd's Current ratio is 4.19, has a Net margin is -600, sales per share of $0.01.

Question 3

How is Mesoblast Ltd's revenue broken down by segment or geography?

Accepted Answer

Mesoblast Ltd largest revenue segment is Cell Technology Platform, at a revenue of 9,006,727 in the most earnings release.For geography, Australia, United States, Singapore, United Kingdom and Switzerland is the primary market for Mesoblast Ltd, at a revenue of 9,006,727.

Question 4

Is Mesoblast Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Mesoblast Ltd has a net loss of $-102

Question 5

Does Mesoblast Ltd have any liabilities?

Accepted Answer

yes, Mesoblast Ltd has liability of 187

Question 6

How many outstanding shares for Mesoblast Ltd?

Accepted Answer

Mesoblast Ltd has a total outstanding shares of 1,279.93

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	17	17	5	7	10	7
Revenue Growth (YoY)	240%	240%	-28.99%	-30%	43%	-78%
Cost of Revenue	5	5	15	27	30	32
Gross Profit	12	12	-9	-20	-20	-25
Selling, General & Admin	39	39	23	25	27	30
Research & Development	34	34	23	25	31	51
Operating Expenses	94	94	57	42	53	65
Other Non Operating Income (Expenses)	0	0	--	--	--	--
Pretax Income	-101	-101	-88	-82	-91	-99
Income Tax Expense	0	0	0	0	0	0
Net Income	-102	-102	-87	-81	-91	-98
Net Income Growth	17%	17%	7%	-11%	-7%	27%
Shares Outstanding (Diluted)	1,273.28	1,207.79	986.7	779.49	684.42	638.18
Shares Change (YoY)	13%	22%	27%	14%	7%	21%
EPS (Diluted)	-0.08	-0.08	-0.08	-0.1	-0.13	-0.15
EPS Growth	-4%	-5%	-15%	-21%	-14%	5%
Free Cash Flow	-50	-50	-48	-63	-65	-102
Free Cash Flow Per Share	-0.03	-0.04	-0.04	-0.08	-0.09	-0.15
Gross Margin	70.58%	70.58%	-180%	-285.71%	-200%	-357.14%
Operating Margin	-482.35%	-482.35%	-1,320%	-885.71%	-730%	-1,285.71%
Profit Margin	-600%	-600%	-1,739.99%	-1,157.14%	-910%	-1,400%
Free Cash Flow Margin	-294.11%	-294.11%	-960%	-900%	-650%	-1,457.14%
EBITDA	--	-82	-65	-61	-72	-89
EBITDA Margin	--	-482.35%	-1,300%	-871.42%	-720%	-1,271.42%
D&A For EBITDA	--	0	1	1	1	1
EBIT	-82	-82	-66	-62	-73	-90
EBIT Margin	-482.35%	-482.35%	-1,320%	-885.71%	-730%	-1,285.71%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Mesoblast Ltd (MEOBF) Price

MEOBF Stock Price Chart

MEOBF Income

Follow-Up Questions